KVUE

MKT CAP:$33B

Kenvue Inc.

Market Cap

$33B

Consumer Defensive·Household & Personal Products·🇺🇸 United States·NYSE

Consumer Def.·Household·🇺🇸·NYSE

Stock Price

$17.43+$0.11 (+0.61%)

Apr 24, 2026

Company Details

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive he...

CEO

Kirk L. Perry

IPO Date

May 4, 2023

Website

www.kenvue.com

Key Metrics TTM

Revenue

$15.1B

-2.1% YoY

Net Income

$1.5B

EPS (Diluted)

$0.77

Free Cash Flow

$1.7B

Revenue / Share

$7.88

Gross Margin

58.1%

Operating Margin

17.9%

Net Margin

9.7%

FCF Margin

11.4%

P/S

2.2x

P/E

22.8x

Earnings Reports

Q1 2026

May 14, 2026

PENDING

FY 2025

Feb 20, 2026

$15.1B-2.1%EPS $0.76

Q4 2025

Feb 20, 2026

$3.8B+3.2%EPS $0.17

Q3 2025

Nov 3, 2025

$3.8B-3.5%EPS $0.21

Q2 2025

Aug 7, 2025

$3.8B-4.0%EPS $0.22

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 21	$3.7B	$2.0B	$506M
Q1 22	$3.6B	$2.0B	$611M
Q2 22	$3.8B	$2.1B	$845M
Q3 22	$3.8B	$2.1B	$823M
Q4 22	$3.8B	$2.1B	$634M
Q1 23	$3.9B	$2.1B	$640M
Q2 23	$4.0B	$2.2B	$702M
Q4 23	$3.7B	$2.0B	$460M
Q1 24	$3.9B	$2.2B	$550M
Q2 24	$4.0B	$2.4B	$154M
Q3 24	$3.9B	$2.3B	$654M
Q4 24	$3.7B	$2.1B	$483M
Q1 25	$3.7B	$2.2B	$558M
Q2 25	$3.8B	$2.3B	$692M
Q3 25	$3.8B	$2.2B	$629M
Q4 25	$3.8B	$2.1B	$825M

Valuation

Quarter	P/S	P/E
Q4 21	—	—
Q1 22	—	—
Q2 22	—	—
Q3 22	3.4x	23.8x
Q4 22	3.4x	24.4x
Q1 23	3.3x	25.1x
Q2 23	3.2x	27.0x
Q4 23	2.7x	26.1x
Q1 24	2.6x	26.7x
Q2 24	2.2x	30.9x
Q3 24	2.9x	41.7x
Q4 24	2.6x	39.4x
Q1 25	3.0x	43.5x
Q2 25	2.6x	28.3x
Q3 25	2.1x	21.9x
Q4 25	2.2x	22.4x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 21	$1.0B	$886M
Q1 22	$338M	$301M
Q2 22	$807M	$731M
Q3 22	$736M	$633M
Q4 22	$644M	$485M
Q1 23	$802M	$747M
Q2 23	$742M	$665M
Q4 23	$950M	$727M
Q1 24	$287M	$134M
Q2 24	$440M	$350M
Q3 24	$249M	$190M
Q4 24	$793M	$661M
Q1 25	$428M	$249M
Q2 25	$621M	$533M
Q3 25	$294M	$196M
Q4 25	$854M	$744M

Capital Expenditures

Quarter	CapEx
Q4 21	$123M
Q1 22	$37M
Q2 22	$76M
Q3 22	$103M
Q4 22	$159M
Q1 23	$55M
Q2 23	$77M
Q4 23	$223M
Q1 24	$153M
Q2 24	$90M
Q3 24	$59M
Q4 24	$132M
Q1 25	$179M
Q2 25	$88M
Q3 25	$98M
Q4 25	$110M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	+0.8%	-3.0%
Q1 23	+7.3%	+7.8%
Q2 23	+5.7%	+12.1%
Q4 23	-3.1%	+8.3%
Q1 24	+3.5%	+6.8%
Q2 24	+3.8%	+19.7%
Q3 24	-2.8%	-1.9%
Q4 24	-0.1%	-0.8%
Q1 25	-3.9%	-4.8%
Q2 25	-4.0%	-18.2%
Q3 25	-3.5%	-3.4%
Q4 25	+3.2%	-7.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 21	$35M	0.9%
Q1 22	$35M	1.0%
Q2 22	$41M	1.1%
Q3 22	$30M	0.8%
Q4 22	$31M	0.8%
Q1 23	$35M	0.9%
Q2 23	$38M	0.9%
Q4 23	$113M	3.1%
Q1 24	$81M	2.1%
Q2 24	$61M	1.5%
Q3 24	$58M	1.5%
Q4 24	$54M	1.5%
Q1 25	$44M	1.2%
Q2 25	$37M	1.0%
Q3 25	$25M	0.7%
Q4 25	$30M	0.8%

OpEx Breakdown

Quarter	R&D	SG&A
Q4 21	—	$1.5B
Q1 22	—	$1.4B
Q2 22	$94M	$1.2B
Q3 22	$90M	$1.2B
Q4 22	$103M	$1.3B
Q1 23	—	$1.5B
Q2 23	—	$1.5B
Q4 23	—	$1.6B
Q1 24	—	$1.6B
Q2 24	—	$1.6B
Q3 24	—	$1.6B
Q4 24	—	$1.5B
Q1 25	—	$1.5B
Q2 25	—	$1.5B
Q3 25	—	$1.5B
Q4 25	—	$1.5B

Revenue Segments

Quarter	Essential Health	Self Care	Skin Health and Beauty
Q1 23	$1.1B	$1.6B	$1.1B
Q4 23	$1.1B	$1.5B	$1.0B
Q1 24	$1.1B	$1.7B	$1.1B
Q2 24	$1.3B	$1.6B	$1.1B
Q3 24	$1.2B	$1.6B	$1.1B
Q1 25	$1.1B	$1.7B	$977M
Q2 25	$1.2B	$1.6B	$1.1B
Q3 25	$1.2B	$1.6B	$1.0B
Q4 25	$1.1B	$1.6B	$1.0B

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 22	$797M	$0	$797M
Q4 22	$1.2B	$0	$1.2B
Q1 23	$1.7B	$0	$1.7B
Q2 23	$1.2B	$0	$1.2B
Q3 23	$1.1B	$0	$1.1B
Q4 23	$1.4B	$0	$1.4B
Q1 24	$1.2B	$0	$1.2B
Q2 24	$1.0B	$0	$1.0B
Q3 24	$1.1B	$0	$1.1B
Q4 24	$1.1B	$0	$1.1B
Q1 25	$1.1B	$0	$1.1B
Q2 25	$1.1B	$0	$1.1B
Q3 25	$1.1B	$0	$1.1B
Q4 25	$1.1B	$0	$1.1B

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 21	1.89B	—	—
Q1 22	1.89B	0.0%	—
Q2 22	1.91B	+1.4%	—
Q3 22	1.72B	-10.4%	—
Q4 22	1.72B	+0.0%	-9.1%
Q1 23	1.72B	-0.0%	-9.2%
Q2 23	1.91B	+11.6%	0.0%
Q4 23	1.92B	+0.0%	+11.6%
Q1 24	1.92B	+0.3%	+11.8%
Q2 24	1.92B	0.0%	+11.9%
Q3 24	1.92B	+0.2%	+0.5%
Q4 24	1.93B	+0.3%	+0.7%
Q1 25	1.93B	-0.2%	+0.3%
Q2 25	1.93B	+0.1%	+0.4%
Q3 25	1.92B	-0.2%	-0.1%
Q4 25	1.92B	-0.2%	-0.5%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 21	—	—
Q1 22	—	—
Q2 22	—	—
Q3 22	—	—
Q4 22	—	—
Q1 23	—	—
Q2 23	—	—
Q4 23	$166.6K	22K
Q1 24	$177.0K	22K
Q2 24	$181.8K	22K
Q3 24	$177.2K	22K
Q4 24	$166.5K	22K
Q1 25	$170.0K	22K
Q2 25	$174.5K	22K
Q3 25	$171.1K	22K
Q4 25	$171.8K	22K

Revenue / Employee